Lucid Diagnostics Inc (NAS:LUCD)

$ 0.788 0.021 (2.74%) Market Cap: 45.52 Mil Enterprise Value: 99.85 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 44/100

Q3 2024 Lucid Diagnostics Inc Earnings Call Transcript
Nov 13, 2024

$1.05 (+5.00%)

Earnings
Q2 2024 Lucid Diagnostics Inc Earnings Call Transcript
Aug 12, 2024

$0.84 (+6.33%)

Earnings
Q1 2024 Lucid Diagnostics Inc Earnings Call Transcript
May 13, 2024

$0.95 (+0.59%)

Earnings
Q4 2023 Lucid Diagnostics Inc Earnings Call Transcript
Mar 26, 2024

$0.99 (-6.60%)

Earnings
Q3 2023 Lucid Diagnostics Inc Earnings Call Transcript
Nov 14, 2023

$1.3 (+12.07%)

Earnings
Q2 2023 Lucid Diagnostics Inc Earnings Call Transcript
Aug 15, 2023

$1.49 (+0.34%)

Earnings
Lucid Diagnostics Inc Annual Shareholders Meeting Transcript
Jun 21, 2023
Q4 2022 Lucid Diagnostics Inc Earnings Call Transcript
Mar 14, 2023

$1.72 (+6.83%)

Earnings
PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call Transcript
Jan 17, 2023
Q3 2022 Lucid Diagnostics Inc Earnings Call Transcript
Nov 14, 2022

$2.27 (+1.79%)

Earnings
Q2 2022 Lucid Diagnostics Inc Earnings Call Transcript
Aug 15, 2022

$3.35 (-1.18%)

Earnings
Lucid Diagnostics Inc Annual Shareholders Meeting Transcript
Jun 21, 2022
Q1 2022 Lucid Diagnostics Inc Earnings Call Transcript
May 11, 2022

$1.86 (-7.46%)

Earnings
Lucid Diagnostics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 12, 2022

Q3 2024 Lucid Diagnostics Inc Earnings Call Transcript

Nov 13, 2024 / 01:30PM GMT

Release Date Price: $1.05 (+5.00%)

Transcript 8-K10-Q

Operator

Good morning and welcome to the Lucid diagnostics third quarter, 2024 business update conference call at this time. All lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call, you require immediate assistance. Please press star zero for the operator. Please note that this event is being recorded.

I would now like to turn the conference over to Matt Riley who does the diagnosis director of investor relations. Please go ahead.

Matt Riley

Lucid Diagnostics Inc - Director of Investor Relations

Thank you operator and good morning everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr Leha ACOG, Chairman and Chief Executive Officer of Lucid Diagnostics along with Dennis mcgrath, Chief Financial Officer of Lucid. The press release announcing our business update and financial results is available on lucids website. Please take a moment to read the disclaimers about forward-looking statements in the press release, the business

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.